Brewin Dolphin LTD Akero Therapeutics, Inc. Transaction History
Brewin Dolphin LTD
- $2.08 Billion
- Q2 2022
Shares
1 transactions
Others Institutions Holding AKRO
# of Institutions
209Shares Held
66.9MCall Options Held
321KPut Options Held
558K-
Rtw Investments, LP New York, NY6.86MShares$310 Million3.11% of portfolio
-
Janus Henderson Group PLC London, X06.03MShares$273 Million0.09% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$253 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$237 Million5.21% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.32MShares$195 Million0.01% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.1B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...